Patients & Caregivers
About HAE
Healthcare Professionals
Clinical Trials
Presentations & Publications
Investors & News
Annual Meeting
Stock Information
News Releases
Event Calendar
Presentations
SEC Filings
Analyst Coverage
Corporate Governance
About
About Us
Senior Management
Board of Directors
Science
Pipeline
Pipeline
Sebetralstat
Oral Factor XIIa Inhibitor
Careers
Careers
Job Openings
Contact
Rapid Plasma Kallikrein Inhibition Following Oral KVD900 Is Associated With Early Symptom Relief in Patients With Hereditary Angioedema
Duckworth EJ, Feener EP, Yea CM, Audhya P, Hampton SL, Smith MD
AAAAI 2022